BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 34624861)

  • 1. The meningioma surface factor: a novel approach to quantify shape irregularity on preoperative imaging and its correlation with WHO grade.
    Popadic B; Scheichel F; Pinggera D; Weber M; Ungersboeck K; Kitzwoegerer M; Roetzer T; Oberndorfer S; Sherif C; Freyschlag CF; Marhold F
    J Neurosurg; 2022 Jun; 136(6):1535-1541. PubMed ID: 34624861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Predicting histological grade in symptomatic meningioma by an objective estimation of the tumoral surface irregularity.
    Delgado-López PD; Montalvo-Afonso A; Martín-Alonso J; Martín-Velasco V; Diana-Martín R; Castilla-Díez JM
    Neurocirugia (Astur : Engl Ed); 2024; 35(3):113-121. PubMed ID: 38244923
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Predicting the risk of postoperative recurrence and high-grade histology in patients with intracranial meningiomas using routine preoperative MRI.
    Spille DC; Adeli A; Sporns PB; Heß K; Streckert EMS; Brokinkel C; Mawrin C; Paulus W; Stummer W; Brokinkel B
    Neurosurg Rev; 2021 Apr; 44(2):1109-1117. PubMed ID: 32328854
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Preoperative radiologic classification of convexity meningioma to predict the survival and aggressive meningioma behavior.
    Liu Y; Chotai S; Chen M; Jin S; Qi ST; Pan J
    PLoS One; 2015; 10(3):e0118908. PubMed ID: 25786236
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Histopathological prognostic factors of recurrence following definitive therapy for atypical and malignant meningiomas.
    Kim D; Niemierko A; Hwang WL; Stemmer-Rachamimov AO; Curry WT; Barker FG; Martuza RL; Oh KS; Loeffler JS; Shih HA
    J Neurosurg; 2018 Apr; 128(4):1123-1132. PubMed ID: 28621619
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A radiopathological classification of dural tail sign of meningiomas.
    Qi ST; Liu Y; Pan J; Chotai S; Fang LX
    J Neurosurg; 2012 Oct; 117(4):645-53. PubMed ID: 22839654
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dynamic susceptibility contrast and dynamic contrast-enhanced MRI characteristics to distinguish microcystic meningiomas from traditional Grade I meningiomas and high-grade gliomas.
    Hussain NS; Moisi MD; Keogh B; McCullough BJ; Rostad S; Newell D; Gwinn R; Foltz G; Mayberg M; Aguedan B; Good V; Fouke SJ
    J Neurosurg; 2017 Apr; 126(4):1220-1226. PubMed ID: 27285539
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunocytochemical analysis of glucose transporter protein-1 (GLUT-1) in typical, brain invasive, atypical and anaplastic meningioma.
    van de Nes JA; Griewank KG; Schmid KW; Grabellus F
    Neuropathology; 2015 Feb; 35(1):24-36. PubMed ID: 25168354
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chordoid Meningioma: Differentiating a Rare World Health Organization Grade II Tumor from Other Meningioma Histologic Subtypes Using MRI.
    Pond JB; Morgan TG; Hatanpaa KJ; Yetkin ZF; Mickey BE; Mendelsohn DB
    AJNR Am J Neuroradiol; 2015 Jul; 36(7):1253-8. PubMed ID: 25882286
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Significance of Simpson grading system in modern meningioma surgery: integration of the grade with MIB-1 labeling index as a key to predict the recurrence of WHO Grade I meningiomas.
    Oya S; Kawai K; Nakatomi H; Saito N
    J Neurosurg; 2012 Jul; 117(1):121-8. PubMed ID: 22559847
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Correlation between magnetic resonance imaging grading and pathological grading in meningioma.
    Lin BJ; Chou KN; Kao HW; Lin C; Tsai WC; Feng SW; Lee MS; Hueng DY
    J Neurosurg; 2014 Nov; 121(5):1201-8. PubMed ID: 25148010
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clear cell histology portends a worse prognosis than other WHO grade II histologies.
    Soni P; Shao J; Momin A; Lopez D; Angelov L; Mohammadi AM; Barnett GH; Recinos PF; Kshettry VR
    J Neurooncol; 2021 Jan; 151(2):307-312. PubMed ID: 33398533
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Analysis of the results of recurrent intracranial meningiomas treated with re-radiosurgery.
    Kim M; Lee DH; Kim Rn HJ; Cho YH; Kim JH; Kwon DH
    Clin Neurol Neurosurg; 2017 Feb; 153():93-101. PubMed ID: 28081463
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of estrogen receptor in WHO Grade III meningioma: a long-term follow-up study from a single institution.
    Hua L; Zhu H; Li J; Tang H; Kuang D; Wang Y; Tang F; Chen X; Zhou L; Xie Q; Gong Y
    J Neurosurg; 2018 Jun; 128(6):1698-1706. PubMed ID: 28820306
    [TBL] [Abstract][Full Text] [Related]  

  • 15. WHO grade of intracranial meningiomas differs with respect to patient's age, location, tumor size and peritumoral edema.
    Ressel A; Fichte S; Brodhun M; Rosahl SK; Gerlach R
    J Neurooncol; 2019 Nov; 145(2):277-286. PubMed ID: 31578671
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Role of MR Morphology and Diffusion-Weighted Imaging in the Evaluation of Meningiomas: Radio-Pathologic Correlation.
    Ranabhat K; Bishokarma S; Agrawal P; Shrestha P; Panth R; Ghimire RK
    JNMA J Nepal Med Assoc; 2019; 57(215):37-44. PubMed ID: 31080244
    [TBL] [Abstract][Full Text] [Related]  

  • 17. World Health Organization Grade III Meningiomas: A Retrospective Study at an Academic Medical Center.
    Sá-Marta E; Alves JL; Rebelo O; Barbosa M
    World Neurosurg; 2021 May; 149():e877-e893. PubMed ID: 33516862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Correlation of volumetric growth and histological grade in 50 meningiomas.
    Soon WC; Fountain DM; Koczyk K; Abdulla M; Giri S; Allinson K; Matys T; Guilfoyle MR; Kirollos RW; Santarius T
    Acta Neurochir (Wien); 2017 Nov; 159(11):2169-2177. PubMed ID: 28791500
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A retrospective analysis of survival and prognostic factors after stereotactic radiosurgery for aggressive meningiomas.
    Ferraro DJ; Funk RK; Blackett JW; Ju MR; DeWees TA; Chicoine MR; Dowling JL; Rich KM; Drzymala RE; Zoberi I; Simpson JR; Jaboin JJ
    Radiat Oncol; 2014 Jan; 9():38. PubMed ID: 24467972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TERT promoter mutation is associated with worse prognosis in WHO grade II and III meningiomas.
    Biczok A; Kraus T; Suchorska B; Terpolilli NA; Thorsteinsdottir J; Giese A; Tonn JC; Schichor C
    J Neurooncol; 2018 Sep; 139(3):671-678. PubMed ID: 29808339
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.